Page last updated: 2024-09-04

gadolinium dtpa and Bilirubinemia

gadolinium dtpa has been researched along with Bilirubinemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ando, H; Atsukawa, M; Ikejima, K; Nagahara, A; Nakadera, E; Okubo, H; Okubo, T1
Ando, H; Fukada, H; Ikejima, K; Miyazaki, A; Morishige, J; Nakadera, E; Okubo, H; Sorin, Y1

Other Studies

2 other study(ies) available for gadolinium dtpa and Bilirubinemia

ArticleYear
Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment.
    Scientific reports, 2022, 05-12, Volume: 12, Issue:1

    Topics: Aminoisobutyric Acids; Bilirubin; Cyclopropanes; Gadolinium DTPA; Hepacivirus; Hepatitis C; Humans; Hyperbilirubinemia; Lactams, Macrocyclic; Leucine; Magnetic Resonance Imaging; Proline; Quinoxalines; Sulfonamides

2022
Gadoxetic acid-enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C.
    PloS one, 2018, Volume: 13, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Cyclopropanes; Female; Gadolinium DTPA; Hepatitis C; Humans; Hyperbilirubinemia; Lactams, Macrocyclic; Macrocyclic Compounds; Magnetic Resonance Imaging; Male; Middle Aged; Proline; Prospective Studies; Sulfonamides; Time Factors; Treatment Outcome

2018